https://www.selleckchem.com/products/mrtx1257.html
6%) and zidovudine (7.9%) regimens (p0.005). Low baseline CD4 count and development of tuberculosis after ART initiation were significantly (p0.05) associated with treatment failure in univariate analysis. Patients with a low peak CD4 count (adjusted odds ratio [AOR 4.26 95% confidence interval
<ci>
1.83 to 9.88]) and who developed symptoms after ART initiation (AOR 3.77 [95% CI 1.47 to 9.69]) had significantly higher odds of treatment failure in the multivariate analysis (p0.001). Early identification of risk factors